Ignite Creation Date:
2024-05-06 @ 12:17 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01535989
Status:
COMPLETED
Last Update Posted:
2016-06-07
First Post:
2012-01-27
Brief Title:
Study of Inotuzumab Ozogamicin Temsirolimus in Patients With Relapsed or Refractory CD22 B-cell NHLymphoma
Sponsor:
Organization:
Oncology Institute of Southern Switzerland